Unosi

• Simultaneous determination of nimesulide and its impurities in pharmaceutical formulations by reversed-phase high-performance liquid chromatography (2007)

  B. Tubić, B. Ivković, M. Zečević, S. Vladimirov, Simultaneous determination of nimesulide and its impurities in pharmaceutical formulations by reversed-phase high-performance liquid chromatography, ACTA CHIMICA SLOVENICA, Vol. 54, pp. 583 - 590, 2007

• Ispitivanje sadržaja aktivne supstance i degradacionih proizvoda/nečistoća u tabletama nimesulida primjenom reverzno-fazne tečne hromatografije pod visokim pritiskom (2013)

  B. Tubić, I. Vujanović-Kasagić, N. Mihajlica, Ž. Gagić, N. Bubić Pajić, Ispitivanje sadržaja aktivne supstance i degradacionih proizvoda/nečistoća u tabletama nimesulida primjenom reverzno-fazne tečne hromatografije pod visokim pritiskom, Arhiv za farmaciju, Vol. 63, No. 1, pp. 1 - 19, 2013

• Dissolution profile of nimesulide from pharmaceutical preparations for oral use (2016)

  B. Tubić, A. Uzunović, S. Pilipović, Ž. Gagić, Dissolution profile of nimesulide from pharmaceutical preparations for oral use, ACTA CHIMICA SLOVENICA, Vol. 63, No. 1, pp. 193 - 199, 2016

• A new model to determine lipophilicity of 1,2-ethanediamine-N,N’-di-2- (3-cyclohexyl)propanoic acid and 1,3-propanediamine-N,N’-di-2- (3-cyclohexyl)propanoic acid derivatives with antiproliferative activity by combining shake flask procedure and UHPLC-MS method (2017-06)

  B. Tubić, B. Marković, S. Vladimirov, A. Savić, J. Poljarević, T. Sabo, A new model to determine lipophilicity of 1,2-ethanediamine-N,N’-di-2- (3-cyclohexyl)propanoic acid and 1,3-propanediamine-N,N’-di-2- (3-cyclohexyl)propanoic acid derivatives with antiproliferative activity by combining shake flask procedure and UHPLC-MS method, PHARMAZIE, No. 72, pp. 317 - 323, Jun, 2017

• Highly sensitive UHPLC-MS/MS method for quantification of ethylenediamine-N,N′-di-2-(3-cyclohexyl) propanoic acid derivatives in mouse serum (2017-06)

  B. Tubić, B. Marković, S. Vladimirov, S. Ristić, B. Ivković, M. Savić, J. Poljarević, T. Sabo, Highly sensitive UHPLC-MS/MS method for quantification of ethylenediamine-N,N′-di-2-(3-cyclohexyl) propanoic acid derivatives in mouse serum, ACTA CHROMATOGRAPHICA, Vol. 2, No. 29, pp. 235 - 252, Jun, 2017

• Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcinoma (2017-06)

  S. Jungić, B. Tubić, R. Gajanin, Z. Gojković, I. Rakita, Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcinoma, VOJNOSANITETSKI PREGLED, Vol. 3, No. 74, pp. 249 - 255, Jun, 2017

• Prediction of in vivo Bioavailibility by in vitro Characterization of Ethylenediamine Dipropanoic Acid Derivatives with Cytotoxic Activity (2018-03)

  B. Tubić, S. Vladimirov, B. Marković, T. Sabo, Prediction of in vivo Bioavailibility by in vitro Characterization of Ethylenediamine Dipropanoic Acid Derivatives with Cytotoxic Activity, ACTA CHIMICA SLOVENICA, Vol. Vol. 65, No. 1, pp. 59 - 64, Mar, 2018

• Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study. (2018-06)

  U. Glamočlija, B. Tubić, M. Kondža, A. Zolak, N. Grubiša, Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study., CROATIAN MEDICAL JOURNAL, Vol. 59, No. 3, pp. 124 - 131, Jun, 2018

• Estimation of passive gastrointestinal absorption and membrane retention using PAMPA test, quantitative structure-permeability and quantitative structure-retention relationship analyses of ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid and 1,3-propanediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid derivatives (2020-02)

  B. Tubić, V. Dobričić, J. Poljarević, A. Savić, T. Sabo, B. Marković, Estimation of passive gastrointestinal absorption and membrane retention using PAMPA test, quantitative structure-permeability and quantitative structure-retention relationship analyses of ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid and 1,3-propanediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid derivatives, JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, Vol. 184, pp. 1 - 8, Feb, 2020

• Prospective risk assessment of medicine shortages in Europe and Israel: findings and implications (2020-03)

  N. Miljković, B. Godman, M. Kovačević, P. Polidori, B. Tubić, Prospective risk assessment of medicine shortages in Europe and Israel: findings and implications, Frontiers in Pharmacology, Vol. Volume 11, pp. 1 - 14, Mar, 2020

• Evaluation of stability of nimesulide in solid pharmaceutical dosage forms (2006)

  B. Tubić, B. Ivković, B. Marković, M. Zečević, Evaluation of stability of nimesulide in solid pharmaceutical dosage forms, 2006

• Praćenje stabilnosti nimesulida u tabletama (2006-05)

  B. Tubić, R. Đurica, M. Zečević, S. Vladimirov, Praćenje stabilnosti nimesulida u tabletama, May, 2006

• Osvrt na farmakoterapijski asortiman citostatika u Republici Srpskoj (2010)

  S. Jungić, N. Babić, T. Nedimović, B. Tubić, N. Grubiša, S. Vladimirov, Osvrt na farmakoterapijski asortiman citostatika u Republici Srpskoj, IV Hrvatski Kongres farmacije 2010, Zbornik radova pp. 81, 2010

• Role of biomarkers in the development of new medicines for cancers – new challenge for regulatory agencies (2011-09)

  S. Jungić, B. Tubić, Role of biomarkers in the development of new medicines for cancers – new challenge for regulatory agencies, Sep, 2011

• Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC - Efficacy and Safety (Meeting Abstract) (2014)

  S. Jungić, G. Kecman Malčić, I. Rakita, D. Jovanović, R. Gajanin, Z. Marić, Z. Gojković, B. Tubić, Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC - Efficacy and Safety (Meeting Abstract), Annals of Oncology, Vol. 25(2), pp. 68 - 68, 2014

• Bevacizumab in combination with irinotecan and capecitabine as first line treatment for MCRC efficacy and safety. (2014-06)

  S. Jungić, G. Kecman Malčić, I. Rakita, D. Jovanović, R. Gajanin, Z. Marić, T. Biljana, Z. Gojković, Bevacizumab in combination with irinotecan and capecitabine as first line treatment for MCRC efficacy and safety., Annals of Oncology 2014; 25 (Supplement 2):, pp. 68 - 68, Jun, 2014

• Highly sensitive liquid chromatography-tandem mass spectrometry method for quantification of L3 in mouse serum (2015-03)

  B. Tubić, B. Marković, S. Ristić, S. Vladimirov, B. Ivković, D. Stanković, T. Sabo, Highly sensitive liquid chromatography-tandem mass spectrometry method for quantification of L3 in mouse serum, Mar, 2015

• Inter-laboratory transfer of new UHPLC-MS/MS bioanalytical method for non-clinical study (2015-06)

  B. Tubić, S. Vladimirov, B. Marković, Inter-laboratory transfer of new UHPLC-MS/MS bioanalytical method for non-clinical study, Book of abstracts, Jun, 2015

• Highly sensitive ultra-performance liquid chromatography-tandem mass spectrometry method for quantification of DE-EDCP and EDCP in mouse serum (2015-06)

  B. Tubić, B. Marković, S. Vladimirov, D. Stanković, S. Ristić, M. Savić, B. Ivković, S. Vladimirov, T. Sabo, Highly sensitive ultra-performance liquid chromatography-tandem mass spectrometry method for quantification of DE-EDCP and EDCP in mouse serum, Abstract, Jun, 2015

• Estimation of permeabilty on artificial membrane for derivatives of alkandiamine-N,N'-di-2-(3-cyclohexyl)propanoic acid (2016-09)

  B. Tubić, S. Pilipović, M. Petrović, O. Petrović, B. Ivković, B. Marković, S. Vladimirov, Estimation of permeabilty on artificial membrane for derivatives of alkandiamine-N,N'-di-2-(3-cyclohexyl)propanoic acid, Journal of the pharmaceutical association of Serbia, Arh.Farm. Special Issue 1-327, pp. 161 - 162, Sep, 2016